Terms: = Head and neck cancer AND ACVR2A, ACVR2, 92, ENSG00000121989, ACTRII, P27037 AND Treatment
2920 results:
1. High incidence of lung cancer death after curative endoscopic submucosal dissection for superficial esophageal squamous cell carcinoma.
Tajiri A; Tsujii Y; Nishida T; Inoue T; Maekawa A; Kitamura S; Yamaguchi S; Nishihara A; Yamada T; Ogiyama H; Murayama Y; Yamamoto S; Egawa S; Uema R; Yoshihara T; Hayashi Y; Takehara T
Cancer Med; 2024 May; 13(9):e7242. PubMed ID: 38733176
[TBL] [Abstract] [Full Text] [Related]
2. Microsurgical reconstruction for head and neck in patients with end-stage renal disease undergoing dialysis.
Hung CT; Wu MS; Wang CH; Cheng LF; Chou YF; Lee CF; Chen PR; Lee JT
Microsurgery; 2024 May; 44(4):e31186. PubMed ID: 38716649
[TBL] [Abstract] [Full Text] [Related]
3. Nivolumab plus chemotherapy or ipilimumab versus chemotherapy in patients with advanced esophageal squamous cell carcinoma (CheckMate 648): 29-month follow-up from a randomized, open-label, phase III trial.
Kato K; Doki Y; Chau I; Xu J; Wyrwicz L; Motoyama S; Ogata T; Kawakami H; Hsu CH; Adenis A; El Hajbi F; Di Bartolomeo M; Braghiroli MI; Holtved E; Makino T; Blum Murphy M; Amaya-Chanaga C; Patel A; Hu N; Matsumura Y; Kitagawa Y; Ajani J
Cancer Med; 2024 May; 13(9):e7235. PubMed ID: 38716626
[TBL] [Abstract] [Full Text] [Related]
4. Prognostic Significance of Excision Repair Cross-Complementation Group 1 on Circulating Tumor Cells for Nasopharyngeal Carcinoma.
Liu T; Li Y; Song J; Li B; Wang R; Huang T; Qin Y
Cancer Control; 2024; 31():10732748241251562. PubMed ID: 38716503
[TBL] [Abstract] [Full Text] [Related]
5. Association between prognosis and lymph node status using
Ohsawa M; Hamai Y; Emi M; Ibuki Y; Kurokawa T; Yoshikawa T; Hirohata R; Kitasaki N; Okada M
World J Surg; 2024 Mar; 48(3):650-661. PubMed ID: 38686781
[TBL] [Abstract] [Full Text] [Related]
6. The clinical value of iodine-125 seed implantation in the treatment of iodine-refractory differentiated thyroid carcinoma.
Wan Q; Tan L; Tang X; Wang W; Su Y; Wu Z; Ke M; Chen Z
Front Endocrinol (Lausanne); 2024; 15():1327766. PubMed ID: 38686207
[TBL] [Abstract] [Full Text] [Related]
7. Assessment of Thyroid Carcinogenic Risk and Safety Profile of GLP1-RA Semaglutide (Ozempic) Therapy for Diabetes Mellitus and Obesity: A Systematic Literature Review.
Feier CVI; Vonica RC; Faur AM; Streinu DR; Muntean C
Int J Mol Sci; 2024 Apr; 25(8):. PubMed ID: 38673931
[TBL] [Abstract] [Full Text] [Related]
8. Chylous leakage after esophagectomy for esophageal cancer: a systematic review.
Zheng X; Yang X; Lei S
J Cardiothorac Surg; 2024 Apr; 19(1):240. PubMed ID: 38632619
[TBL] [Abstract] [Full Text] [Related]
9. Platinum-based adjuvant chemoradiotherapy versus adjuvant radiotherapy in patients with head and neck adenoid cystic carcinoma.
Qiu Z; Wu Z; Zhou X; Lin M; Su Y; Tao Y
J Cancer Res Clin Oncol; 2024 Apr; 150(4):195. PubMed ID: 38625410
[TBL] [Abstract] [Full Text] [Related]
10. Survival analysis of Sudanese oral squamous cell carcinoma patients with field of cancerization.
Eltohami Y; Suleiman A
BMC Cancer; 2024 Apr; 24(1):473. PubMed ID: 38622532
[TBL] [Abstract] [Full Text] [Related]
11. [Phase Ⅱ clinical trial of PD-1 inhibitor combined with chemotherapy for locally advanced resectable oral squamous cell carcinoma].
Wang HL; Yue K; Wu YS; Duan YS; Jing C; Wang XD
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2024 Apr; 59(4):335-342. PubMed ID: 38599641
[No Abstract] [Full Text] [Related]
12. Pembrolizumab-based first-line treatment for PD-L1-positive, recurrent or metastatic head and neck squamous cell carcinoma: a retrospective analysis.
Cirillo A; Marinelli D; Romeo U; Messineo D; De Felice F; De Vincentiis M; Valentini V; Mezi S; Valentini F; Vivona L; Chiavassa A; Cerbelli B; Santini D; Bossi P; Polimeni A; Marchetti P; Botticelli A
BMC Cancer; 2024 Apr; 24(1):430. PubMed ID: 38589857
[TBL] [Abstract] [Full Text] [Related]
13. Characterization of parotid gland tumors using diffusion-relaxation correlation spectrum imaging: a preliminary study.
Chen W; Geng D; Xu XQ; Hu WT; Dai YM; Wu FY; Zhu LN
Clin Radiol; 2024 Jun; 79(6):e878-e884. PubMed ID: 38582630
[TBL] [Abstract] [Full Text] [Related]
14. Risk of recurrence after neoadjuvant chemotherapy and transoral robotic surgery in patients with oropharynx cancer that avoid adjuvant radiation.
Pershad AR; Thakkar PG; Goodman JF; Joshi A; Steinberg SM; Allen CT; Floudas CS
Cancer Med; 2024 Apr; 13(7):e7146. PubMed ID: 38581118
[TBL] [Abstract] [Full Text] [Related]
15. Preoperative Circulating Tumor HPV DNA and Oropharyngeal Squamous Cell Disease.
Lam D; Sangal NR; Aggarwal A; Rajasekaran K; Cannady SB; Basu D; Chalian A; Weinstein G; Brody RM
JAMA Otolaryngol Head Neck Surg; 2024 May; 150(5):444-450. PubMed ID: 38573644
[TBL] [Abstract] [Full Text] [Related]
16. Quality of Life and Depression Symptoms After Therapy De-Escalation in HPV+ Oropharyngeal Squamous Cell Carcinoma: A Nonrandomized Controlled Trial.
Panwar A; Shah S; Reid AE; Lydiatt W; Holcomb AJ; Osmolak A; Coughlin A; Militsakh O; Su YB; Mirmiran A; Huang TS; Nolan N; Duckert R; Barney C; Chiu M; Nguyen C; Sayles H; Ganti AK; Lindau R
JAMA Otolaryngol Head Neck Surg; 2024 May; 150(5):429-435. PubMed ID: 38573597
[TBL] [Abstract] [Full Text] [Related]
17. Outcomes of transoral robotic surgery for early-stage oropharyngeal squamous cell carcinoma with low rates of adjuvant therapy: A consecutive single-institution study from 2013 to 2020.
Meldgaard Justesen M; Kronberg Jakobsen K; Fenger Carlander AL; Hjordt Holm Larsen M; Wessel I; Kiss K; Friborg J; Ibrahim Channir H; Rubek N; Grønhøj C; von Buchwald C
Oral Oncol; 2024 May; 152():106783. PubMed ID: 38569317
[TBL] [Abstract] [Full Text] [Related]
18. Blood leukocytes as a non-invasive diagnostic tool for thyroid nodules: a prospective cohort study.
Wang F; Zhao D; Xu WY; Liu Y; Sun H; Lu S; Ji Y; Jiang J; Chen Y; He Q; Gong C; Liu R; Su Z; Dong Y; Yan Z; Liu L
BMC Med; 2024 Apr; 22(1):147. PubMed ID: 38561764
[TBL] [Abstract] [Full Text] [Related]
19. Pembrolizumab plus concurrent chemoradiotherapy versus placebo plus concurrent chemoradiotherapy in patients with locally advanced squamous cell carcinoma of the head and neck (KEYNOTE-412): a randomised, double-blind, phase 3 trial.
Machiels JP; Tao Y; Licitra L; Burtness B; Tahara M; Rischin D; Alves G; Lima IPF; Hughes BGM; Pointreau Y; Aksoy S; Laban S; Greil R; Burian M; Hetnał M; Delord JP; Mesía R; Taberna M; Waldron JN; Simon C; Grégoire V; Harrington KJ; Swaby RF; Zhang Y; Gumuscu B; Bidadi B; Siu LL;
Lancet Oncol; 2024 May; 25(5):572-587. PubMed ID: 38561010
[TBL] [Abstract] [Full Text] [Related]
20. Neoadjuvant therapy with chemotherapy and immune checkpoint inhibitor for laryngeal function preservation in locally advanced hypopharyngeal cancer.
Wu SG; Wang RJ; Zhou Y; Luo XY
Front Immunol; 2024; 15():1364799. PubMed ID: 38524124
[TBL] [Abstract] [Full Text] [Related]
[Next]
